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Abstract 
The aim of this study was to examine the effect of 5-HTTLPR and COMT Val158Met 
polymorphism, anxiety, impulsivity, neuroticism and adverse life events on abnormal eating 
behaviors among 25-year-old women. This study is based on ECPBHS (Estonian Children 
Personality, Behaviour and Health Study) older cohort data. Participants answered to State 
and Trait Anxiety Inventory (STAI), Barrat Impulsiveness Scale (BIS-11), NEO-PI Estonian 
version, Eating Disorder Inventory -2 (EDI-2). The sample was genotyped for 5-HTTLPR 
and COMT Val158Met polymorphism. 
The main finding of the current study is that the influence of neuroticism on eating 
disorder symptomatology is mediated mainly by trait anxiety. This study shows consistent 
effects of neuroticism through trait anxiety on bulimic symptoms, body dissatisfaction and 
drive for thinness. Neuroticism through impulsivity influences only bulimic symptoms. 
Trait anxiety can be seen as a stable trait predisposing people toward higher levels of 
eating disorder symptomatology. 
 
Kokkuvõte 
5-HTTLPR, COMT Val158Met polümorfism, negatiivsed elusündmused, neurootilisus, 
ärevus ja impulsiivsus söömishäire sümptomaatika mõjutajatena 
 
Magistritöö eesmärgiks oli uurida 5-HTTLPRi, COMT Val158Met polümorfismi, 
ärevuse, impulsiivsuse, neurotismi ning negatiivsete elusündmuste mõju häirunud 
söömiskäitumise väljakujunemisele 25-aastastel naistel. Magistritöö põhineb Eesti Laste 
Isiksuse, Käitumise ja Tervise Uuringu (ELIKTU) vanema kohordi andmetel. Osalejatelt 
koguti andmed elukäigu, ärevuse (STAI), impulsiivsuse (BIS-11) ning isiksuseomaduste 
kohta (NEO-PI). Andmed söömishäirete sümptomaatika kohta saadi Eating Disorder 
Inventory -2 (EDI-2) abil. Osalejatel määrati 5-HTTLPR ning COMT Val158Met genotüüp. 
Antud tööst selgub, et neurotismi mõju söömishäirete sümptomaatikale on vahendatud 
püsiärevuse poolt. Antud tööst tuleb välja sarnane mõju nii buliimilistele sümptomitele, 
kehaga rahulolematusele kui kõhnuseihalusele. Neurotismi mõju on vahendatud ka 
impulsiivsuse poolt, kuid mõju on oluline vaid buliimilistele sümptomitele. 
Püsiärevust võib näha kui faktorit, mis soodustab häirunud söömiskäitumise 
väljakujunemist. 
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Introduction 
Eating disorders 
Eating disorders are persistent disturbances of eating behavior or behavior intended to 
control weight (Fairburn & Walsh, 2002). These complex illnesses most often strike during 
adolescence or young adulthood and are more common among females than males. (Herzog, 
Franko, & Cable, 2008) 
People with eating disorders share some common symptoms. They are occupied with 
negative thoughts and intense emotions about their body size and shape. They adopt 
unhealthy weight control practices and other abnormal eating habits, taking these measures to 
a dangerous extreme. (Herzog et al., 2008) 
According to The Diagnostic and Statistical Manual of Mental Disorders, Text 
Revision, eating disorders are classified as anorexia nervosa (AN), bulimia nervosa (BN), and 
eating disorder not otherwise specified (EDNOS) (American Psychiatric Association [DSM-
IV-TR], 2000). In International Classification of Diseases Version 10 (World Health 
Organization [ICD-10], 1992) eating disorders are classified under behavioral syndromes that 
are associated with physiological disturbances and physical factors together for example with 
sleep and sexual disorders. Eating disorders refer to a group of conditions defined by 
abnormal eating habits and involve 8 disorders in ICD-10. Besides AN and BN other eating 
disorders classified in ICD-10 are atypical anorexia nervosa, atypical bulimia nervosa, binge 
eating associated with other psychological disturbances, vomiting associated with other 
psychological disturbances, other eating disorders, eating disorder unspecified. (ICD-10, 
1992) 
Diagnostic criteria for anorexia nervosa (DSM-IV-TR, 2000) involve desire to 
maintain weight at or above a minimally normal weight for age and height or maintaining 
weight at less than 85 percent normal; intense fear of gaining weight or becoming fat, even 
though underweight; disturbance in experience of body weight or shape, or undue influence 
of body weight or shape on self-evaluation, or denial of the seriousness of current low body 
weight; amenorrhea in postmenarcheal females, defined as the absence of three consecutive 
menstrual cycles in girls or women who have started having periods. 
Diagnostic criteria for bulimia nervosa include recurrent episodes of binge eating 
which are characterized both by consuming larger than normal amounts of food and by 
feeling out of control while bingeing; recurrent inappropriate compensatory behavior to 
prevent weight gain (e.g. excessive exercise, fasting, vomiting); and being “unduly 
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influenced” by body shape and weight (DSM-IV-TR, 2000). There are two subtypes of 
bulimia, purging and non-purging (Rumney, 2009). 
Eating Disorder Not Otherwise Specified (EDNOS) is a category for patients who do 
not meet the above-mentioned criteria for any specific eating disorders (DSM-IV-TR, 2000). 
Disordered eating is an important problem in today’s society. Statistics show that 
more than 8 million people in the United States suffer from eating disorders, and many more 
have substantially abnormal eating habits that don’t meet the formal criteria for classification 
as illness (Herzog et al., 2008). Estimated number of individuals with disordered eating 
behavior in European Union is currently considered to be 1.2 million (Wittchen & Jacobi, 
2005). 
It is difficult to establish accurate prevalence rates for eating disorders but 
epidemiological studies assessing eating disorder prevalence show that lifetime prevalence 
for anorexia nervosa is 0.3-0.9%, bulimia nervosa 1-1.5% and for binge eating disorder 1-
3.5% (Hoek & van Hoeken, 2003; Hudson, Hiripi, Pope, & Kessler, 2007). In Estonia, the 
current prevalence of eating disorders in women is 0.7% for restrictive anorexia nervosa 
(AN-R), 1.4% for bulimia nervosa purging type (BN-P), 1.8% for binge eating disorder 
(BED) and 3.8% for EDNOS. The prevalence of eating disorders in men is 0.5% for BED 
and 0.5% for EDNOS (Akkermann, 2010). 
Many ED patients have other mental health problems at the same time. Depressive 
symptoms and anxiety features are particularly common among individuals with disordered 
eating behavior since most patients meet criteria for one or more mood or anxiety disorders 
(Fairburn, 2008). 
 
Risk factors 
Despite the lack of clarity in eating disorders prevalence, it is clear that they impact 
the quality of life. Low treatment success for eating disorders (Steinhausen, 2002) and high 
mortality rate (Uher, 2009) are some of the main reasons why it is important to learn more 
about risk factors so practitioners could detect high risk individuals and prevent them from 
developing eating disorders. 
It has been estimated that fewer than 50% of AN patients achieve full recovery, 33% 
improve and 20% remain chronically ill. Also, 33% of those who recover relapse (Herzog & 
Eddy, 2007). Only 1/3 of anorexic patients and about 6% of subjects with BN receive mental 
health care (Hoek & van Hoeken, 2003). 
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It is important to note that many patients may not meet full diagnostic criteria for a 
diagnosis of eating disorder but they will exhibit significantly disordered eating. Patients with 
disordered eating patterns who do not meet eating disorder criteria are still at risk for 
complications (Walsh, Wheat, & Freund, 2000). Disordered eating behavior disables physical 
health and psychosocial functioning (Fairburn & Walsh, 2002). 
One thorough meta-analysis listed risk factors that include such factors as female 
gender, Caucasian race, childhood eating and digestive problems, anxiety, over concern with 
weight and shape, body dissatisfaction/negative body image, high drive for thinness, sexual 
abuse and other adverse life events (for a review please see Jacobi, Hayward, de Zwaan, 
Kraemer, & Stewart Agras, 2004). 
Stice (2002) identified several risk factors which are important for the onset and 
maintenance of the disorders and these are for example body dissatisfaction, negative affect, 
and maladaptive coping skills. Mazzeo & Bulik (2009) stated the importance of genes as ED 
risk factors. 
 
Adverse life events 
Stressful life events are classified as risk factors for eating disorders and it is found 
that sexual abuse increases the risk at most (Jacobi et al., 2004). Though, it has been shown 
that there are a number of other stressful life events to increase the risk of disordered eating 
behavior (Loth, van den Berg, Eisenberg, & Neumark-Sztainer, 2008). Both clinical studies 
and population based studies show the connection between eating disorders and stressful life 
events (Loth et al., 2008; Schmidt, Tiller, Blanchard, Andrews, & Treasure, 1997; Welch, 
Doll, & Fairburn, 1997). Problems with sexuality predispose to anorexia (Schmidt et al., 
1997) and BN patients experience more negative life events before the onset of the disorder 
as compared to AN patients (Welch et al., 1997). 
It has been found recently that the combination of low social support and multiple 
negative life events predict bulimic symptoms but not restrictive eating or anxiety or mood 
symptoms (Bodell, Smith, Holm-Denoma, Gordon, & Joiner, 2011). 
Garfinkel et al (1995) argued that childhood adversities may lead to several forms of 
affective disorders and eating disorders psychopathologies by reducing self-esteem and 
magnifying one’s sense of helplessness and body dissatisfaction. 
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Anxiety 
Anxiety is a displeasing feeling of fear and concern (Davidson, 2008). It is long 
acting, future focused, broadly focused towards a diffuse threat, and promoting caution while 
approaching a potential threat (Sylvers, Lilienfeld, & LaPrairie, 2011). 
Adverse life events can cause distress. Distress tolerance or anxiety management is a 
construct related to appraisal and coping processes (Folkman & Lazarus, 1980). High 
avoidance of affect and low acceptance and management of problems are negative 
components of distress tolerance associated with anxiety and disordered eating attitudes 
(Corstorphine, Mountford, Tomlinson, Waller, & Meyer, 2007). 
Anxiety is common among individuals with ED patients (Bulik, Sullivan, & Kendler, 
2002) as compared to healthy individuals. Eating disorders are highly comorbid with 
affective disorders, anxiety disorders and personality disorders (Godart, Flament, Perdereau, 
& Jeammet, 2002; Mitchell, Specker, & de Zwaan, 1991). It has been shown that also 
individuals with subclinical eating disorders show more anxious and depressive symptoms 
(Touchette et al., 2011). 
Pallister & Waller (2008) suggested three potential explanations for the comorbidity 
between anxiety and eating disorders - anxiety could be a risk factor for ED or itself may 
cause anxiety, or these disorders may have common shared vulnerabilities. 
It is not clear how anxiety is linked to disordered eating behavior although recent 
study by Kaye, Bulik, Thornton, Barbarich, & Masters (2004) have shown that anxiety 
disorders tend to precede the development of eating disorders. 
 
Impulsivity 
According to Eysenck, Pearson, Easting, & Allsop (1985) impulsivity is a 
dimensional personality trait which leads to behaving without stopping to think. 
Patients with bulimia nervosa have been found to have higher global impulsivity 
scores using Barrett‘s Impulsivity Scale, than the nonclinical population and patients with 
anorexia nervosa restrictive subtype (Rosval, Steiger, Bruce, Israël, Richardson, & Aubut, 
2006). BN has been associated with high impulsivity by Kemps & Wilsdon (2010) as well. 
Jacobi et al. (2004) found that impulsive behaviour among bulimic patients is related 
to decreased serotonin levels in central nervous system, the same results have been shown by 
Steiger et al. (2001) as well. Yet, Racine, Culbert, Larson, & Klump (2009) did not find any 
associations between impulsivity, 5-HT genes and binge eating disorder. 
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Neuroticism 
According to McCrae & Costa (1990) personality traits are enduring dimensions of 
individual differences in tendencies to show consistent patterns of thoughts, feelings, and 
actions. These traits are basic tendencies, rooted in biology that can resist the influences of 
environment (Allik & McCrae, 2002). 
 It has been shown that out of Big Five personality traits (for a full review see Costa & 
McCrae, 1992) neuroticism and extraversion affect disordered eating the most (Brookings & 
Wilson, 1994). Neuroticism is defined as the propensity to experience negative emotions 
(Eysenck, Eysenck, & Barret, 1985). Neuroticism includes emotions like irritability, sadness, 
anxiety, worry, hostility, self-conscientiousness, and vulnerability - all of these are correlated 
to one another (Costa & McCrae, 1992). 
Persons with high neuroticism scores are more likely than other persons to develop 
anxiety and depression following negative life events (Jacobs, Kenis, Peeters, Derom, 
Vlietinck, & van Os, 2006). Recently Dahl et al. (2012) confirmed that individuals with 
disordered eating behavior report more depressive and anxious feelings and neuroticism. 
Negative urgency, the tendency to act rashly when distressed, appears to be a 
particularly important risk factor for binge eating behavior (Fischer, Smith, & Cyders, 2008). 
Positive associations between neuroticism and eating disorders have also been 
demonstrated (Bulik et al., 2002; Cassin & von Ranson, 2005). For example Podar (2010) 
showed very strong correlations between EDI-2 subscales and neuroticism and suggested that 
it is possible to consider eating disorder symptoms as an aspect of neurotic personality 
dispositions. 
 
Serotonin transporter gene promoter region polymorphism (5-HTTLPR) 
There is growing evidence that genetic variants contribute to the pathogenesis of 
eating disorders. It has been suggested that there are a number of genes that code for proteins 
that influence traits that index vulnerability to these disorders (Mazzeo & Bulik, 2009). 
People with eating disorders have disturbances in neurotransmitting regulations that 
involve serotonin and dopamine system and that can be conditioned by genes (Mikolajczyk, 
Grzywacz, & Samochowiec, 2010) Thus it is important to study the genes underlying these 
neurotransmitters regulation. 
It has been suggested that serotonin transporter gene is a good candidate gene for 
eating pathology. Human serotonin transporter is encoded by one gene (SLC6A4) in 
chromosome 17 (Gelernter, Pakstis, & Kidd, 1995). The serotonin transporter gene mediates 
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sodium dependent presynaptic reuptake of serotonin, thus terminating serotonergic 
neurotransmission. 
The short or s-allele has been associated with trait anxiety (Lesch et al., 1996; Sen et 
al., 2004), affective instability (Lesch & Mössner, 1998; Steiger et al., 2005) and greater 
amygdale reactivity to emotion-related stimuli (Hariri et al., 2002). 
Several lines of evidence indicate that disturbances of 5-HT neurotransmission 
contribute to various expressions of eating pathology, but in many studies no allelic 
differences in 5-HTTLPR have been found (Hinney et al., 1997; Lauzurica et al., 2003; 
Monteleone, Tortorella, Castaldo, & Maj, 2006; Rybakowski, Slopien, Dmitrzak-Weglarz, 
Czerski, Rajewski, & Hauser, 2006; Steiger et al., 2005; Sundaramurthy, Pieri, Gape, 
Markham, & Campbell, 2000; Urwin, Bennetts, Wilcken, Beumont, Russell, & Nunn, 2003). 
Some studies have associated long or l-allele with bulimic symptoms (Matsushita, 
Nakamura, Nishiguchi, & Higuchi, 2002; Monteleone, Tortorella, Castaldo, & Maj, 2006) 
and overweight (Fumeron, Betoulle, Aubert, Herbeth, Siest, & Rigaud, 2001). Also, it has 
been found that s-allele (especially s/s genotype) is more frequent in individuals with 
anorexia nervosa (Fumeron et al., 2001; Matsushita, Suzuki, Murayama, Nishiguchi, & 
Hishimoto, 2004). S-allele, and especially the s/s genotype increases the risk for affective 
instability and symptom severity in disordered eating behavior (Akkermann, Nordquist, 
Oreland, & Harro, 2010). 
 
Catechol-O-methyltransferase (COMT) gene Val158Met polymorphism 
In the frontal regions of the brain, serotonin is theorized to contribute to regulating 
dopamine: when serotonin levels decrease, dopamine levels rise, and vice versa (Kapur & 
Remington, 1996; Sasaki-Adams & Kelley, 2001). Catechol-O-methyltransferase (COMT) is 
largely responsible for the metabolism of dopamine and norepinephrine in the prefrontal 
cortex (Enoch, Waheed, Harris, Albaugh, & Goldman, 2009). The role of COMT in 
dopamine metabolism has led to investigation of its variants in the etiology of numerous 
psychiatric disorders including psychotic, affective and anxiety disorders (Funke et al., 2005). 
The catechol-O-methyltransferase (COMT) gene encodes the COMT enzyme 
responsible for degrading catecholamines, including dopamine and norepinephrine, 
particularly in frontal areas of the brain (Matsumoto et al., 2003). To date, one of the most 
studied variants of the COMT gene has been the G/A single nucleotide polymorphism 
resulting in valine–methionine substitution at codon 158 (Val158Met; rs4680). Functional 
studies have identified the Val158Met polymorphism as a marker of trimodal function (Chen 
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et al., 2004), leading to high (Val/Val), intermediate (Val/Met), and low (Met/Met) enzyme 
activities. 
The Met allele has been associated with more anxious, cautious personality (Enoch, 
Xu, Ferro, Harris, & Goldman, 2003). Met allele has been associated with mood as well as 
anxiety disorders (Hosak, 2007). On the other hand the study based on selected cases and 
controls from a large twin cohort found the Val allele to predict both higher neuroticism and 
risk for anxiety disorders and major depression (Hettema et al., 2008). Some studies show 
marginal (Eley et al., 2003) or no associations between COMT genotype and personality 
traits (Ishii et al., 2007). 
Val allele has been associated with increased risk for eating disorders (Mikolajczyk, 
Smiarowska, Grzywacz, & Samochowiec, 2006). Val/val genotype increases the risk of 
bulimia nervosa (Mikolajczyk et al., 2010). Though there are studies showing that there is no 
association between COMT-rs4680 and eating disorders (Gabrovsek et al., 2004; Yilmaz et 
al., 2011). 
Yilmaz and colleagues (2011) suggested that while the Met allele may be associated 
with BN in general, the presence of the Val-allele, associated with high COMT enzyme 
activity, may serve as a risk factor for a subgroup of BN probands with ADHD symptoms. 
One study concerning both candidate genes (serotonin transporter gene and COMT 
gene) showed that carriers of at least one Met-allele of the COMT gene had significantly 
higher total scores of the EDI-2. Carriers of the s-allele of the 5-HTTLPR had significantly 
higher scores of the EDI-2 drive for thinness and body dissatisfaction subscales (Frieling et 
al., 2006). 
 
Interaction between genes and environment  
Several studies show interaction effect of 5-HTTLPR variations and adverse life 
events on depression (Caspi et al., 2003; Cervilla et al., 2007; Kendler, Kuhn, Vittum, & 
Prescott, 2005; Wilhelm et al., 2006), although Gillespie, Whitfield, Williams, Heath, & 
Martin (2005) found no interaction effect between 5-HTT gene polymorphism and life events 
on depression. S-allele carriers have greater and longer lasting reactions to fearful stimuli 
(Armbruster, Moser, Strobel, Tilman, Kirschbaum, Lesch, & Brocke 2009). 
Our previous study showed that the effect of the 5-HTTLPR on binge eating and on 
drive for thinness was moderated by adverse life events and sexual abuse in particular 
(Akkermann, Kaasik, Kiive, Nordquist, Oreland, & Harro, 2012). 
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It has been recently shown that childhood adverse experience is moderated by the 
COMT genotype in a way that Met allele carriers who have experienced childhood adverse 
life events have higher risk of developing severe alcohol dependence compared to individuals 
homozygous for the Val allele (Schellekens, Franke, Ellenbroek, Cools, de Jong, Buitelaar, & 
Verkes, 2012). 
 
Aim of the study 
 Based on previous findings, the study was conducted to examine the relationship 
between 5-HTTLPR and COMT Val158Met polymorphisms adverse life events, neuroticism, 
anxiety, impulsivity and disordered eating behavior and attitudes. 
 
Method 
Participants 
The study is based on the sample of the European Youth Heart Study (EYHS) which 
was first conducted in Estonia in 1998/1999, then complemented with psychology module 
and incorporated into the longitudinal Estonian Children Personality, Behavior and Health 
Study (ECPBHS). Sample formation is described in detail by Harro et al. (2001) study. This 
sample represents the proportion of certain aged urban and rural girls and boys living in one 
county at the time of sampling. The main unit of sampling was a school. Out of 54 schools 
that agreed to participate were selected 25 schools using cluster sampling. Of each sampled 
school all of the selected aged students were asked to participate and written consent was 
given by children and their parents. 
This study is based on the data of the older cohort who participated in the study in 1998 (N = 
593, mean age 15.4 years, SD = 0.6 years), 2001 (N = 417, mean age 18.3, SD = 07 years) 
and 2008 (mean age 24.7, SD = 0.7, N = 541). Data about female subjects was used, men 
were excluded due to the low prevalence of disordered eating in men. Subjects completed 
several questionnaires in laboratory setting, descriptive statistics are presented in table 1. The 
study was approved by the Ethics Review Committee on Human Research of the University 
of Tartu. The study was conducted in accordance with the Declaration of Helsinki. 
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Table 1 
Descriptive statistics of the sample 
Measure Mean SD Min result Max result 
Bulimia  1.31 2.15 0 15 
Drive for Thinness  3.48 4.24 0 18 
Body Dissatisfaction  7.31 7.10 0 27 
Neuroticism  93.76 24.24 39 160 
State anxiety (STAI-S) 33.13 9.93 20 75 
Trait anxiety (STAI-T) 41.69 11.13 22 71 
Impulsivity (BIS-11) 56.56 8.56 36 82 
Adverse life events 2.47 2.44 0 10 
 
 
Genotyping of the 5-HTTLPR and COMT Val158Met polymorphism 
Genomic DNA extraction from venous blood and genotyping was carried out in 
Department of Neuroscience, Pharmacology, University of Uppsala, Sweden. 
The alleles at the 5-HTTLPR locus were amplified from genomic DNA using 
polymerase chain reaction (PCR) as described previously by Harro et al. (2001). 
DNA was extracted from venous blood with QIAamp DNA Midi kit (Qiagen, Hilden, 
Germany). COMT Val158Met polymorphism (rs4680) genotyping reactions were performed 
in a total volume of 20 µl with 10-50 ng of template DNA. The real-time polymerase chain 
reaction was performed with primers and fluorescent probes obtained from Applied 
Biosystems (Foster City, CA, USA) Custom TaqMan SNP Genotyping Assays. PCR reaction 
components and final concentrations were as follows: 1:5 5xHOT FIREPol Probe qPCR Mix 
Plus (ROX) (SolisBiodyne) and 1:20 80xTaqMan Primers Probe (F 5’ -
CCCAGCGGATGGTGGAT -3’; R 5’ –CAGGCATGCACACCTTGTC –3’; Reporter 1 –
TTCGCTGGCATGAAG (VIC); Reporter 2 –TCGCTGGCGTGAAG (FAM)). Reactions 
were performed on the ABI 7500 Real-Time PCR system and the amplification procedure 
consisted of an initial denaturation step at 95°C for 15 minutes and 40 cycles of 95°C for 15 
seconds and 60°C for 1 minute. All genotyping reactions were carried out in duplicates and 
extra negative controls were added to each reaction plate. No inconsistencies occurred. 
Genotypes were found to be in the Hardy-Weinberg equilibrium. 
 
Measures 
Eating Disorders Inventory – 2 (EDI-2) (Garner, 1991), Estonian version (Podar et al., 
1999) three subscales – drive for thinness (DT), bulimia (B) and body dissatisfaction (BD) – 
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were used to assess eating behavior and attitudes. Information about disordered eating 
behavior was collected in 2008. The drive for thinness subscale measures concern and 
preoccupation with dieting and weight gain, the bulimia subscale measures the tendency to 
think about and engage in episodes of binge eating and body dissatisfaction subscale 
measures dissatisfaction with the overall shape and with the size of those parts of the body 
that are of greatest concern to those with eating disorders (i.e. stomach, hips, thighs, 
buttocks). These subscales have been shown to be most directly related to eating-disordered 
behavior (Hurley et al., 1990). 
Anxiety was measured by Estonian version of State and Trait Anxiety Inventory 
(STAI) (Spielberger et al., 1983; Kreegipuu, 1997). The data were collected in 2008. 
Personality factors were measured in 2001 by NEO Personality Inventory (NEO-PI) 
(Costa & McCrae, 1985) adapted Estonian version (Pulver, Allik, Pulkkinen, & Hämäläinen, 
1995). This model consists of neuroticism, extraversion, openness to experience, 
agreeableness, and conscientiousness. 
Estonian version of Barratt Impulsiveness Scale (BIS-11) (Paaver et al., 2007; Patton 
et al., 1995) was used to measure impulsivity in 2008. In data analysis was used the total 
score of BIS-11. 
Participants completed a comprehensive list about their life events, which was 
composed by Department of Public Health in University of Tartu. In the list there were 23 
questions about adverse life events such as physical and mental violence, sexual abuse, 
trauma etc. Events were recorded dichotomously – present or not present during lifetime. 
Data about adverse life events was collected in the second study wave in 2001. 
 
Data analysis 
Statistical analysis was made using SPSS version 17.0 and STATA version 12. 
Current analysis is based on previous studies. Descriptive statistics and dispersion analysis 
were carried out using SPSS Statistics. The author performed path analysis using least 
squares method to show the associations between 5-HTTLPR, COMT Val158Met 
polymorphism, adverse life events, neuroticism and the moderating effect of anxiety and 
eating disorders. All the necessary assumptions were met and diagnostics are shown in 
appendix. 
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Results 
Genotypes 
In our sample 333 women were genotyped for 5-HTTLPR. S-allele carriers were 
grouped into one group since genetic studies have shown that s/s and s/l genotypes are similar 
and both different from l/l homozygotes (Lesch et al., 1996). There were 134 (40%) l-
homozygous and 199 (60%) s-allele carrier women. 
332 women were genotyped for COMT gene - 67 (20%) were Val-homozygotes, 171 
(52%) Val/Met heterozygotes and 94 (28%) Met-homozygotes. In the data analysis all three 
allelic versions were analyzed separately. 
 
Adverse life events 
The subjects were ranked ordered and then divided into three equal groups based on 
percentiles with each group consisting of 33.33% of total cases: individuals with no adverse 
life events, individuals with few (1-2 events) and moderate (three or more) history of adverse 
life events. 
No statistically significant differences between 5-HTTLPR s-allele carriers and l/l 
homozygotes concerning the number of adverse life events, F(1,227) = 0.15, p = .70, were 
observed. Statistically significant differences between COMT Val158Met allelic variants on 
the frequency of adverse life events, F(2,226) = 2.99, p = .05, were shown. Post hoc 
comparisons using the Fisher LSD test revealed that Val/Met heterozygous individuals had 
experienced less adverse life events as compared to Val/Val (p < .05) and Met/Met (p < .05). 
homozygotes. 
 
Anxiety 
5-HTTLPR was not associated with trait anxiety (STAI-T) mean scores, F(1,200) = 
0.22, p = .64, nor state anxiety (STAI-S), F(1,200) = 0.27, p = .61 mean scores. COMT 
genotype was not associated with trait and state anxiety. 
Groups based on different levels of adverse life events (as described above) had 
statistically different levels of trait anxiety, ANOVA main effect of adverse life events on 
trait anxiety was proven at p = .02, F(2,226) = 3.87. Post hoc comparisons using the Fisher 
LSD test revealed that individuals who had experienced three or more adverse life events had 
higher trait anxiety mean scores compared to individuals who had experienced one or two 
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adverse life events (p < .05). The group with no history of adverse life events did not differ 
from other two groups regarding anxiety mean score (p > .05). 
 These kind of associations were present regarding state anxiety as well, ANOVA 
main effect of adverse life events on state anxiety was proven at p = .03, F(2,227) = 3.75. 
Post hoc comparisons using the Fisher LSD test revealed that individuals who had 
experienced three or more adverse life events had higher state anxiety mean scores compared 
to other two groups (individuals with no history of adverse life events, p < .05, and 
individuals who had experienced one or two adverse life events in the past, p < .05). The 
group with no history of adverse life events did not differ statistically significantly (p > .05) 
from the group with one or two adverse life events. 
 
Impulsivity 
According to one way ANOVA neither the 5-HTTLPR allelic variants based groups 
nor COMT genotype based groups differed in levels of impulsivity (p = .48 and .38, 
respectively). Impulsivity was not associated to previously experienced adverse life events (p 
= .30). There was a significant positive correlation between impulsivity and trait anxiety 
scores (r = .39, p < .001). 
 
Neuroticism 
5-HTTLPR had no effect on neuroticism F(1,214) = 0.10, p = .75. ANOVA main 
effect of COMT genotype on trait anxiety was near significant at p = .07, F(2,213) = 2.67. 
Post hoc comparisons using the Fisher LSD test revealed that Val/Met heterozygotes had 
lower levels of neuroticism compared to Val/Val homozygotes (p = .03). Met/Met 
homozygotes did not differ statistically significantly (p > .05) from two other groups. 
Neuroticism was correlated with higher levels of reported adverse life events at the 
age of 18 (r = .26, p < .001). There was a significant positive correlation between impulsivity 
and neuroticism scores (r = .39, p < .001) as well. 
 
Disordered eating behavior 
5-HTTLPR allelic variations and COMT Val158Met genotype were not associated 
with either EDI-2 drive for thinness, p > .05, or bulimia scores, p > .05. Influence of 5-
HTTLPR on body dissatisfaction was not statistically significant, F(1,264) = 3.36, p = .07, 
but there was a tendency that s-allele carriers were more satisfied with their body as 
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compared to l/l homozygotes according to post hoc comparisons using the Fisher LSD test. 
COMT genotype was also associated with EDI-2 body dissatisfaction score, F(2,263) = 4.25, 
p = .02. Post hoc comparisons using the Fisher LSD test revealed that Val/Met heterozygotes 
had lower body dissatisfaction scores compared to Val/Val (p < .05) and Met/Met 
homozygotes (p = .06). Met/Met homozygotes did not differ statistically significantly (p > 
.05) from Val/Val homozygotes. 
Adverse life events had near significant ANOVA main effect on EDI-2 bulimia, 
F(2,223) = 2.59, p = .08, drive for thinness F(2,218) = 2.87, p = .06, and body dissatisfaction 
F(2,218) = 2.55, p = .08 score. Post hoc comparisons using the Fisher LSD test revealed that 
regarding drive for thinness, individuals who had experienced three or more adverse life 
events had higher drive for thinness mean scores compared to other two groups (individuals 
with no history of adverse life events, p < .05, and individuals who had experienced one or 
two adverse life events in the past, p < .05). The group with no history of adverse life events 
did not differ statistically significantly (p > .05) from the group with one or two adverse life 
events regarding drive for thinness. Same kinds of tendencies were seen regarding bulimia 
and body dissatisfaction but these were not statistically significant. 
Trait anxiety (low, medium, high score) was associated with bulimia, F(2,216) = 
20.22, p < .001, drive for thinness, F(2,210) = 17.94, p < .001, and body dissatisfaction, 
F(2,211) = 12.20, p < .001, mean scores. Post hoc comparisons using the Fisher LSD test 
revealed in all three cases at p < .05 that the groups with higher trait anxiety had higher EDI-
2 bulimia, drive for thinness and body dissatisfaction scores. All three groups differentiated 
from each other. 
Impulsivity was associated with bulimia, F(2,176) = 4.85, p = .01) but not with drive 
for thinness (p = .17) and body dissatisfaction (p = .23). Post hoc comparisons using the 
Fisher LSD test revealed that individuals with high impulsivity had higher bulimia scores 
comparing to individuals with low (p = .01) and medium (p = .01) impulsivity. Individuals 
who had low or medium scores in impulsivity did not differ from each other regarding 
bulimic symptomatology.  
 
Interaction effect between genes and environment 
There was no interaction effect of the 5-HTTLPR and adverse life events on EDI-2 
bulimia subscale scores, p = .55, drive for thinness, p = .20, and body dissatisfaction, p = .37, 
respectively.  
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There was no interaction effect of the COMT genotype and adverse life events on 
EDI-2 subscales as well, all of the significance values were higher than .60. 
Because univariate ANOVA showed no interaction effect of genes and adverse life 
events on EDI-2 subscales the gene x environment interaction was not included to the 
following pathway regression analysis. 
 
Pathway regression analysis 
The author made path analysis for three EDI-2 subscales – bulimia, drive for thinness, 
body dissatisfaction. The parameters of following pathway models (Fig. 1-6) were estimated 
by STATA 12 by using pathreg command (“Introduction to STATA”, 2007). The command 
carries out necessary regression analysis for estimation of standardized coefficients by using 
ordinary least squares regression estimates. The fulfillment of regression model assumptions 
were tested and analyzed by diagnostic tests for each sub-regression model of pathway 
regression models. Path regression analysis tables and diagnostics are presented in appendix. 
Categorical (genetic) variables were incorporated in models as dummy (as described by 
Wooldridge, 2002) variables. Each pathway regression model consists of two regression 
models. 
 
EDI-2 Bulimia subscale 
By modeling the direct and indirect (through trait anxiety – STAI-T) effects of 5-
HTTLPR, adverse life events and neuroticism on EDI-2 bulimia subscale only the indirect 
effects of neuroticism through trait anxiety (STAI-T) were statistically significant (β = .53; p 
< .05). Also the direct effect of trait anxiety on bulimia subscale was confirmed (β = .45; p < 
.05) while also controlling for direct effects of 5-HTTLPR, adverse life events and 
neuroticism on bulimia result of which none itself was statistically significant (p > .05). Still 
it can be seen that standardized errors of predicted variable of predicted variables STAI-T (ε1 
= .84) and bulimia (ε1 = .88) were substantial. It can be concluded that the predictive power 
of variables and relationships modeled by pathway model is quite low. 
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Figure 1. Direct and indirect (through trait anxiety) effects of 5-HTTLPR, adverse life events 
and neuroticism on EDI-2 bulimia subscale. 
 
Next, the author included COMT gene Val158Met polymorphism to the model 
instead of 5-HTTLPR as it is shown in figure 2. In this model we have chosen Val/Val 
genotype to be the base group as benchmark group, that is, the group against which 
comparisons are made (as described in Wooldridge, 2002). By modeling the direct effect and 
indirect effect through trait anxiety of COMT gene Val158Met polymorphism, adverse life 
events and neuroticism on EDI-2 bulimia subscale only the indirect effects of neuroticism 
through trait anxiety were statistically significant (β = .52; p < .05). Also the direct effect of 
trait anxiety on bulimia subscale was confirmed (β = .44; p < .05) while also controlling for 
direct effects of COMT gene Val158Met polymorphism, adverse life events and neuroticism 
on bulimia subscale result of which none was statistically significant (p > .05). Similarly to 
previous model, here are substantial standardized errors of predicted variable of predicted 
variables STAI-T (ε1 = .84) and bulimia (ε1 = .88). It can be concluded that the predictive 
power of variables and relationships between them modeled by pathway model is quite low. 
 
5-HTTLPR, COMT, adverse life events, anxiety, eating disorders 
 
19
 
Figure 2. Direct and indirect (through trait anxiety) effects of COMT gene polymorphism, 
adverse life events and neuroticism on EDI-2 bulimia subscale. 
 
EDI-2 Drive for Thinness subscale 
Similar to first two models, the effects were the same regarding drive for thinness 
(Figure 3). The indirect effects of neuroticism through trait anxiety (STAI-T) were 
statistically significant (β = .53; p < .05) on drive for thinness result. Also the direct effect of 
trait anxiety on drive for thinness subscale was confirmed (β = .43; p < .05) while also 
controlling for direct effects of 5-HTTLPR, adverse life events and neuroticism on drive for 
thinness subscale of which none was statistically significant (p > .05). Standardized errors of 
predicted variable of predicted variables STAI-T (ε1 = .84) and drive for thinness (ε1 = .91) 
were substantial. The predictive power of variables and relationships between them modeled 
by pathway model is quite low. 
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Figure 3. Direct and indirect (through trait anxiety) effects of 5-HTTLPR, adverse life events 
and neuroticism on EDI-2 drive for thinness subscale. 
 
We included COMT gene Val158Met polymorphism to the model instead of 5-
HTTLPR as it is shown in figure 4. By modeling the direct effect and indirect effect through 
trait anxiety of COMT gene polymorphism, adverse life events and neuroticism on EDI-2 
drive for thinness subscale only the indirect effects of neuroticism through trait anxiety were 
statistically significant (β = .52; p < .05). Also the direct effect of trait anxiety on drive for 
thinness subscale was confirmed (β = .42; p < .05) while also controlling for direct effects of 
COMT gene polymorphism, negative life events and neuroticism on symptomatology scale of 
bulimia of which none was statistically significant (p > .05). Standardized errors are 
substantial. 
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Figure 4. Direct and indirect (through trait anxiety) effects of COMT gene polymorphism, 
adverse life events and neuroticism on EDI-2 drive for thinness subscale. 
 
EDI-2 Body Dissatisfaction subscale 
Figure 5 shows similar results that neuroticism influences body dissatisfaction 
statistically significantly (β = .53; p < .05) through trait anxiety which itself influences body 
dissatisfaction (β = .34; p < .05). In this model, adverse life events had nearly significant 
direct effect on body dissatisfaction result (β = .14; p = .06). 
 
Figure 5. Direct and indirect (through trait anxiety) effects of 5-HTTLPR, adverse life events 
and neuroticism on EDI-2 body dissatisfaction subscale. 
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Figure 6 shows that COMT gene Val158Met polymorphism, adverse life events and 
neuroticism did not affect body dissatisfaction directly but neuroticism influences statistically 
significantly through trait anxiety. 
By modeling the direct effect and indirect effect via trait anxiety of COMT gene 
Val158Met polymorphism, adverse life events and neuroticism on EDI-2 body dissatisfaction 
subscale only the indirect effects of neuroticism through trait anxiety were statistically 
significant (β = .52; p < .05). Also the direct effect of trait anxiety on body dissatisfaction 
subscale was confirmed (β = .34; p < .05) while also controlling for direct effects of COMT 
gene polymorphism, negative life events and neuroticism on body dissatisfaction of which 
none was statistically significant (p > .05). In this model the tendency of direct effect of 
adverse life events on body dissatisfaction can be seen (p = .09). Also COMT genotype 
effect, where Val/Met heterozygous individuals had lower body dissatisfaction scores as 
compared to Val/Val homozygotes. The same results were observed by dispersion analysis as 
well. There are substantial standardized errors of predicted variables STAI-T (ε1 = .84) and 
bulimia (ε1 = .92). It can be concluded that the predictive power of variables and 
relationships between them modeled by pathway model is quite low. 
 
 
Figure 6. Direct and indirect (through trait anxiety) effects of COMT gene polymorphism, 
adverse life events and neuroticism on EDI-2 body dissatisfaction subscale. 
 
It should be concluded that all six models (Fig. 1-6) acted the same way by modeling 
the direct and indirect (through trait anxiety) effects of 5-HTT or COMT gene Val158Met 
polymorphism, adverse life events and neuroticism on EDI-2 bulimia, drive for thinness and 
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body dissatisfaction subscales. Only the indirect effects of neuroticism through trait anxiety 
(STAI-T) were statistically significant. Also the direct effect of trait anxiety was confirmed in 
each model while controlling for direct effects of gene polymorphisms, adverse life events 
and neuroticism on eating disorder. Because all the pathway regression models presented 
above showed substantial size of error terms it can be concluded that the predictive power of 
variables and relationships between them modeled by pathway models is quite low. 
 
Impulsivity and EDI-2 Bulimia subscale 
Based on the findings that bulimic patients tend to be more impulsive as compared to 
healthy individuals the author conducted pathway regression analysis to show the effect of 
impulsivity on disordered eating behavior. Models regarding impulsivity and bulimic 
symptomatology are presented in appendix. Similarly to anxiety models impulsivity models 
acted the same way by modeling the direct and indirect (through impulsivity) effect of 5-
HTTLPR and COMT Val158Met polymorphism, adverse life events and neuroticism on EDI-
2 bulimia scores. Although the author formed the models regarding three EDI-2 subscales - 
bulimia, drive for thinness and body dissatisfaction - the model was correctly specified 
according to Ramsey RESET test only when looking for associations between impulsivity 
and bulimic symptoms (fig. 7). This is in accordance with ANOVA results. 
In the model including 5-HTTLPR, adverse life events, neuroticism, impulsivity and 
bulimia (fig. 7), only the effect of neuroticism on impulsivity was statistically significant (β = 
.35; p < .05). The direct effect of impulsivity on bulimia was not statistically significant (β = 
.17; p = .05). Standardized errors were even more substantial as compared to models 
including trait anxiety and the predictive power was lower than in previous models. 
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Figure 7. Direct and indirect (through impulsivity) effects of 5-HTTLPR, adverse life events 
and neuroticism on EDI-2 bulimia subscale. 
 
In the model including COMT Val158Met polymorphism, only the indirect effect of 
neuroticism through impulsivity on bulimia scores was statistically significant (β = .35; p < 
.05) (Fig. 8) It should be said that adverse life events had a tendency to affect impulsivity (β 
= .14, p = .08). The direct effect of impulsivity (β = .19; p < .05) was confirmed while 
controlling for direct effects of COMT gene polymorphisms, adverse life events and 
neuroticism on bulimia of which none was statistically significant. The direct effect of 
COMT Val158Met polymorphism was also confirmed – Met/Met homozygotes had 
decreased EDI-2 bulimia scores as compared to Val/Val homozygotes (β = -.21, p < .05). 
Effect was not seen comparing Val/Val homozygotes to Val/Met heterozygotes (p = .38). 
Standardized errors were even more substantial as compared to models including trait 
anxiety. 
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Figure 8. Direct and indirect (through impulsivity) effects of COMT Val158Met 
polymorphism, adverse life events and neuroticism on EDI-2 bulimia subscale. 
 
Discussion 
This study showed no 5-HTTLPR or COMT Val158Met polymorphism main effects 
on eating disorder symptoms regarding EDI-2 bulimia and drive for thinness scores. These 
results are consistent with number of previous findings (Gabrovsek et al., 2004; Hinney et al., 
1997; Lauzurica et al., 2003; Urwin et al., 2003; Yilmaz et al., 2011). Although we found that 
both genetic polymorphisms are associated with body dissatisfaction. The tendency that s-
allele carriers are less dissatisfied with their body weight and shape as compared to l/l 
homozygotes was contrary to general theory. These results are somewhat inconsistent with 
previous findings by Fumeron et al. (2001) who found that s-allele is more frequent among 
AN patients. Although AN patients are satisfied with their body size and weight, body 
dissatisfaction can be seen as the most important predisposing factor for eating disorders. 
Very recent meta-analysis showed that across the studies there are homogeneous 
findings that COMT Val158Met polymorphism is not associated with AN (Brandys et al., 
2012). This study showed no associations between COMT Val158Met polymorphism and 
drive for thinness – one of the most important components of AN – and therefore can confirm 
previous findings. On the other hand we found that body dissatisfaction is affected by 
Val158Met polymorphism. We found the tendency that Val/Met heterozygotes had lower 
neuroticism scores compared to Val/Val and Met/Met homozygotes (p = .07), no associations 
between COMT Val158Met genotype and impulsivity were found. It would be possible to 
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consider body dissatisfaction as an aspect of neurotic personality disposition as it was 
previously suggested by Podar (2010).  
We did not find any associations between 5-HTTLPR and neuroticism nor 
impulsivity. Yet, it has been shown in meta-analysis that 5-HTT gene could be a good 
candidate gene in neuroticism, though the demonstrated effects are small (Schinka, Busch, & 
Robichaux-Keene, 2004). These results should be evaluated carefully because possible weak 
genetic components would need more substantial sample size to be statistically significantly 
distinguishable. 
It has been shown in number of previous works that adverse life events are strongly 
related to disordered eating behavior (Pike, Wilfley, Hilbert, Fairburn, Dohm, & Stiegel-
Moore, 2006; Risch et al., 2009; Welch et al., 1997). This study is consistent with previous 
findings. The frequency of adverse life events in the past was associated with eating disorder 
symptomatology at age of 25. Results were near significant regarding bulimic symptoms, 
body dissatisfaction and drive for thinness. Individuals with no history of adverse life events 
and individuals with few adverse life events do not differ from each other regarding body 
dissatisfaction, bulimia and drive for thinness. This was statistically significant regarding 
drive for thinness and same kind of tendencies were seen regarding body dissatisfaction and 
bulimic symptoms as well.  
Previously we have reported the interaction effect of 5-HTTLPR and adverse life 
events on disordered eating behavior among ECPBHS younger cohort (Akkermann et al. 
2012). This effect was confirmed also by Stoltenberg, Anderson, Nag, & Anagnopoulus 
(2012) who found that female s-allele carriers who were exposed to higher levels of 
childhood trauma reported significantly higher mean numbers of eating problems. This effect 
was not repeated in the current analysis based on ECPBHS older cohort. Adverse life events 
alone had an effect on eating disorder symptomatology but there was no interaction effect 
between adverse life events and 5-HTTLPR or COMT Val158Met polymorphism. We could 
hypothesize that there is an age-related vulnerability to adverse life events. In this case our 
sample consists of young women who reported about their previous adverse life events at the 
age of 18 years and the effect of adverse life events was considered at the age of 25 years. 
Our previous data was collected among teenage girls reporting about their experienced 
adverse life events at the age of 15 and the effect was considered at the age of 18. Younger 
girls may be more affected by experienced adverse life events. It should also be noted that 
older cohort reported less adverse life events experienced in the past as compared to younger 
cohort. It could be that adverse experiences moderated by genetic factors lead to disordered 
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eating behavior in some people when they have experienced adverse life events frequently. In 
this sample the group with most adverse life events had experienced 3-10 events compared to 
younger cohorts 6-18 events (Akkermann et al., 2012). Caspi et al. (2003) showed that 5-
HTTLPR moderating effect of adverse life events on depression becomes particularly 
important when individuals had experienced more than 4 adverse life events.  
To our best knowledge the current study is the first to explore mediating effect of trait 
anxiety and impulsivity among above mentioned genetic polymorphisms, adverse life events, 
neuroticism and disordered eating.  
It has been shown previously that adverse life events (Loth et al., 2008; Schmidt et al., 
1997; Welch et al., 1997), anxiety (Bulik et al., 2002; Mitchell et al., 1991), neuroticism 
(Brookings & Wilsdon, 1994; Dahl et al., 2012), 5-HTTLPR (Matsushita et al., 2002; 
Monteleone et al., 2006), COMT Val158Met polymorphism (Mikolajczyk et al., 2006; 
Mikolajczyk et al., 2010) can be seen as risk factors for eating disorders. Since EDI-2 
bulimia, drive for thinness and body dissatisfaction subscales are most directly related to 
disordered eating behavior (Hurley et al., 1990), the author conducted pathway regression 
analysis taking into account all of these risk factors to show the relationship between these 
factors and disordered eating behavior. It is important to note that same kind of models were 
made regarding bulimia, drive for thinness and body dissatisfaction subscales and the results 
were the same all across the models. The author showed that eating disorder symptomatology 
is affected directly by trait anxiety. The effect of neuroticism through trait anxiety is 
statistically significant but has no direct effect on eating disorder symptomatology. These 
models show that different eating disorder symptomatology is affected by the same way 
directly by trait anxiety and by neuroticism through trait anxiety. 
It is important to note that these path regression models acted the same way regarding 
all three EDI-2 subscales, so all of the main symptoms of eating disorders are affected in a 
similar way. The construct of control has been linked to anxiety, and it has been 
conceptualized as anxious perception of low control over external threats and emotional 
reactions. (Sassaroli, & Ruggiero, 2011) Perception of control is a general attitude involving 
not only eating and body weight and shape but also external events and internal feelings as 
well, such feelings may cause anxiety. To regain the feeling of control, individuals with ED 
commonly focus on eating and body size. (Sassaroli, & Ruggiero, 2011).  
Is anxiety a cause or an effect of disordered eating behavior? Pallister & Waller 
(2008) suggested three potential explanations for the comorbidity between anxiety and eating 
disorders - anxiety could be a risk factor for ED or itself may cause anxiety, or these 
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disorders may have common shared vulnerabilities. Models of current study show that 
anxiety is a risk factor for eating disorders. All in all the results from this study as well results 
from previous research argue in favor of connection between symptomology of eating 
disorders and trait anxiety.  
It is hypothesized that if a person is not very distress tolerant then she can develop 
eating disorders. In the current study adverse life events were associated with trait anxiety as 
was shown by dispersion analysis. In path regression analysis regarding neuroticism and 5-
HTTLPR of COMT Val158Met genotype besides adverse life events the effect was not 
significant any more. This argues in favor to hypothesis that the level of anxiety cannot be 
explained away as a result of differences of environment between subjects. Rather anxiety 
can be seen as stable trait predisposing people toward higher levels of eating disorder related 
symptomology. The hypothesis was also supported by fact that trait anxiety was strongly 
influenced by personality dimension neuroticism that has been shown to be quite stable 
across life (Allik & McCrae, 2002). 
We did not report that trait anxiety is influenced by 5-HTTLPR and COMT 
Val158Met polymorphism. The main finding of current study is that although it has been 
suggested that neuroticism affects disordered eating behavior directly (Bulik et al., 2002; 
Cassin & von Ranson, 2005; Fischer, Smith, & Cyders, 2008) we found that the influence is 
important only through trait anxiety. Our study has shown that trait anxiety and neuroticism 
are significantly related to eating disorders symptomology. So the author suggests that further 
studies targeting candidate genes for eating disorders should consider including the genes 
related to constructs of neuroticism and trait anxiety.  
It has been shown that impulsivity is particularly associated with BN (Kemps & 
Wilsdon, 1994; Rosval et al., 2006). This study showed that EDI-2 bulimia subscale mean 
scores were associated with impulsivity. These kinds of associations were not present 
regarding body dissatisfaction or drive for thinness. Further, the author conducted pathway 
regression analysis adding 5-HTTLPR or COMT Val158Met polymorphism, adverse life 
events, neuroticism to the model together with impulsivity and EDI-2 bulimia subscale 
results to the model. This model showed that neuroticism affects bulimic symptomatology 
through impulsivity when genetic polymorphism of COMT Val158Met was included in the 
model. The effect of impulsivity on bulimic symptoms was not statistically significant when 
5-HTTLPR was part of the model. Other factors besides impulsivity and neuroticism did not 
affect bulimic symptomatology directly or through impulsivity either when considering 
COMT Val158Met polymorphism or 5-HTTLPR effect in the model. These models are not 
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optimal for modeling influences on drive for thinness and body dissatisfaction because there 
are no significant associations between these variables.  
We showed that impulsivity had significant effect on bulimic symptoms only when 
COMT Val158Met genotype was present in a model. This could be explaned by the 
hypothezis that inhibitory control is sensitive to dopamine function.  Congdon, Constable, 
Lesch, & Canli (2009) found that COMT Met-allele carriers compared to Val/Val 
homozygotes had greater activation during inhibition. 
This study supports the kind of treatment for ED where it is important to target the 
underlying vulnerability cognitions and anxiety as suggested by Pallister & Waller (2008). 
Anxiety has been linked to the construct of control. The perception of low control over 
external threats and emotional reactions increases anxiety. To regain the feeling of control, 
individuals with ED commonly focus on eating and body size (Sassaroli, & Ruggiero, 2011). 
The findings from current study hint that practitioners should investigate eating 
problems among individuals with mood and anxiety disorders as suggested previously by 
Touchette et al. (2011). 
In this study we used nonclinical sample and therefore it is unclear whether the kind 
of relationships would extend to individuals with clinical eating disorders and this should be 
examined in the future.  
Another limitation of this study is our sample. The author was able to analyze only 
disordered eating symptomatology not diagnosed cases because of low incidence of 
diagnosed eating disorders. Future studies should investigate the applicability of these kinds 
of models among clinical population. Also it should be important to examine how some 
protective factors (for example social support) change the pathways to eating disorder 
symptoms. 
 
Conclusion 
This study shows no 5-HTTLPR or COMT Val158Met polymorphism effect on 
disordered eating behavior regarding bulimic symptoms and drive for thinness. Body 
dissatisfaction was influenced by both polymorphisms. 
The main finding of current study is that although it has been suggested that 
neuroticism affects disordered eating behavior directly we found that the influence is 
mediated mainly by trait anxiety and modestly by impulsivity. Neuroticism seems to be 
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particularly important personality factor to affect impulsivity, anxiety and eating disorders as 
well through these factors. 
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Appendix 
Analysis regarding EDI-2 Bulimia subscale 
 
Table 1 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
-1.25 1.51 -0.83 .41 -.05 
Negative life events 
 
0.34 0.31 1.12 .27 .07 
Neuroticism 0.24 0.03 7.88 .00 .53 
Constant 
 
20.68 3.70 5.58 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Bulimia Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.09 0.02 5.42 .00 .45 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
0.27 0.31 0.86 .39 .06 
Negative life events 
 
0.04 0.06 0.59 .56 .04 
Neuroticism 0.00 0.00 0.15 .89 .01 
Constant 
 
-2.96 0.83 -3.59 .00 . 
n = 169 2R  = .22 sqrt (1 - 2R ) = .88 
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Table 2 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
COMT Val/Met as dummy 
variable 
 
0.07 1.84 0.04 .97 .00 
COMT Met/Met as dummy 
variable 
 
-1.35 2.18 -0.62 .54 -.05 
Negative life events 
 
0.38 0.31 1.23 .22 .08 
Neuroticism 
 
0.24 0.03 7.75 .00 .52 
Constant 
 
18.93 3.38 5.60 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Bulimia Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.08 0.02 5.29 .00 .44 
COMT Val/Met as a 
dummy variable 
 
0.28 0.37 0.75 .45 .07 
COMT Met/Met as a 
dummy variable 
 
-0.27 0.45 -0.62 .54 -.05 
Negative life events 
 
0.05 0.06 0.79 .43 .06 
Neuroticism 0.00 0.01 0.33 .74 .03 
Constant 
 
-2.70 0.75 -3.59 .00 . 
n = 169 2R  = .23 sqrt (1 - 2R ) = .88 
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Analysis regarding Drive for Thinness 
 
Table 3 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
-1.25 1.51 -0.83 .41 -.05 
Negative life events 
 
0.34 0.31 1.12 .27 .07 
Neuroticism 0.24 0.03 7.88 .00 .53 
Constant 
 
20.68 3.70 5.58 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Drive for Thinness Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.17 0.03 5.07 .00 .43 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
0.65 0.64 1.01 .31 .07 
Negative life events 
 
0.18 0.13 1.38 .17 .10 
Neuroticism -0.01 0.02 -0.89 .38 -.08 
Constant 
 
-3.55 1.71 -2.07 .04 . 
n = 169 2R  = .18 sqrt (1 - 2R ) = .91 
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Table 4 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
COMT Val/Met as a 
dummy variable 
 
0.07 1.84 0.04 .97 .00 
COMT Met/Met as a 
dummy variable 
 
-1.35 2.18 -0.62 .54 -.05 
Negative life events 
 
0.38 0.31 1.23 .22 .08 
Neuroticism 
 
0.24 0.03 7.75 .00 .52 
Constant 
 
18.94 3.38 5.60 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Drive for Thinness Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.16 0.03 4.95 .00 .42 
COMT Val/Met as a 
dummy variable 
 
-0.34 0.78 -0.44 .66 -.04 
COMT Met/Met as a 
dummy variable 
 
-0.63 0.93 -0.68 .50 -.06 
Negative life events 
 
0.18 0.13 1.35 .18 .10 
Neuroticism -0.01 0.02 -0.84 .40 -.07 
Constant 
 
-2.09 1.57 -1.33 .19 . 
n = 169 2R  = .18 sqrt (1 - 2R ) = .91 
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Analysis regarding EDI-2 Body Dissatisfaction 
 
Table 5 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
-1.25 1.51 -0.83 .41 -.05 
Negative life events 
 
0.34 0.31 1.12 .27 .07 
Neuroticism 0.24 0.03 7.88 .00 .53 
Constant 
 
20.68 3.70 5.58 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Body Dissatisfaction Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.22 0.06 3.83 .00 .33 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
-1.01 1.13 -0.90 .37 -.07 
Negative life events 
 
0.44 0.23 1.90 .06 .14 
Neuroticism -0.01 0.03 -0.55 .58 -.05 
Constant 
 
0.37 3.02 0.12 .90 . 
n = 169 2R  = .14 sqrt (1 - 2R ) = .93 
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Table 6 
Pathway Analysis 
STAI-T Coef. Std. Err. t P > | t | Beta 
COMT Val/Met as a 
dummy variable 
 
0.07 1.84 0.04 .97 .00 
COMT Met/Met as a 
dummy variable 
 
-1.35 2.18 -0.62 .54 -.05 
Negative life events 
 
0.38 0.31 1.23 .22 .08 
Neuroticism 
 
0.24 0.03 7.75 .00 .52 
Constant 
 
18.94 3.38 5.60 .00 . 
n = 169 2R  = .30 sqrt (1 - 2R ) = .84 
 
 
Body Dissatisfaction Coef. Std. Err. t P > | t | Beta 
STAI-T 
 
0.23 0.06 3.92 .00 .34 
COMT Val/Met as a 
dummy variable 
 
-2.35 1.37 -1.72 .09 -.16 
COMT Met/Met as a 
dummy variable 
 
-1.38 1.62 -0.85 .40 -.08 
Negative life events 
 
0.40 0.23 1.71 .09 .13 
Neuroticism -0.02 0.03 -0.82 .41 -.07 
Constant 
 
0.89 2.74 0.33 .75 . 
n = 169 2R  = .15 sqrt (1 - 2R ) = .92 
 
Diagnostics 
To test the fulfillment of regression model assumptions all the regression models of 
pathway regression models were carried out separately and then analyzed by appropriate 
diagnostic tests to check for multicollinearity by using TOL and VIF statistics, 
heteroskedasticity by using Breusch-Pagan test and model specification errors in terms of 
omitted variables by using Ramsey RESET test.  
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Regression model with error terms without constant variation across the range of 
factor variables (heteroskedasticity) can cause the erroneous estimations of standard error 
estimates of regression model parameters. Having erroneous model parameter’s standard 
error estimates can cause wrong results in statistical test of statistical significance of model 
parameters. In models with detected heteroskedasticity new model with robust standard error 
estimates adjusted to heteroskedasticity was calculated in order to estimate the statistical 
significance of model parameters. 
All such separate regression models satisfy the assumption of nonexistence of 
multicollinearity determined by comparing obtained TOL and VIF values against critical 
values (VIF > 5; TOL < 0.20). Also all such separate regression models meet the between the 
number of observations (n) and number of parameters in model (k) n > k. 
 
Table 7 
Regression analysis using least squares method 
STAI-T Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
5-HTTLPR (l/l vs s-
allele carriers) 
 
-1.25 1.51 -0.83 .41 -4.22 1.73 
Neuroticism 0.24 0.03 7.88 .00 0.18 0.30 
Negative life events 
 
0.34 0.31 1.12 .27 -0.26 0.95 
Constant 
 
20.68 3.70 5.58 .00 13.37 28.00 
n = 169 2R  = .30 (Adjusted 2R  = .29)  Root MSE = 9.46 
F(3,165) = 23.87, p = .00 
 
Ramsey RESET test using powers of the fitted values of STAI-T 
HO: model has no omitted variables 
F(3,162) = .69 
Prob > F .56 
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Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of STAI-T 
χ² (1) = .00 
Prob > χ² .97 
 
Regression model analyzing the relationship between dependent variable STAI-T and 
factor variables 5-HTTLPR, negative life events and neuroticism (Table 7) was estimated by 
F-statistic to be statistically significant (p < .05) and described 30% of variance seen in 
dependent variable STAI-T. Only the factor variable neuroticism and constant of model were 
shown to be statistically significant (p < .05). 
The diagnostic tests show that no specification errors in terms of omitted variables 
and heteroskedasticity in significance levels p < .05 can be shown. 
 
Table 8 
Regression analysis using least squares method 
STAI-T Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
COMT Val/Met as a 
dummy variable 
 
0.07 1.84 0.04 .97 -3.57 3.70 
COMT Met/Met as a 
dummy variable 
 
-1.35 2.18 -0.62 .54 -5.66 2.97 
Neuroticism 
 
0.24 0.03 7.75 .00 0.18 0.30 
Negative life events 
 
0.38 0.31 1.23 .22 -0.23 1.00 
Constant 
 
18.94 3.38 5.60 .00 12.26 25.62 
n = 169 2R  = .30 (Adjusted 2R  = .29)  Root MSE = 9.49 
F(4,164) = 17.77, p = .00 
 
Ramsey RESET test using powers of the fitted values of STAI-T 
HO: model has no omitted variables 
F(3,161) = .18 
Prob > F .91 
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Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of STAI-T 
χ² (1) = .10 
Prob > χ² .76 
 
Regression model analyzing the relationship between dependent variable STAIT-T 
and factor variables COMT gene Val158Met polymorphism dummy variables, negative life 
events and neuroticism (Table 8) was estimated by F-statistic to be statistically significant (p 
< .05) and described 30% of variance seen in dependent variable STAI-T. Only the factor 
variable Neuroticism and constant of model were shown to be statistically significant (p < 
.05).  
The diagnostic tests show that no specification errors in terms of omitted variables 
and heteroskedasticity in significance levels p < .05 can be shown.  
 
Table 9 
Regression analysis using least squares method 
Bulimia Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.09 0.02 5.42 .00 0.05 0.12 
5-HTTLPR (l/l vs s-
allele carriers) 
0.27 0.31 0.86 .39 -0.34 0.87 
Neuroticism 0.00 0.01 0.15 .89 -0.01 0.02 
Negative life events 0.04 0.06 0.59 .56 -0.09 0.16 
 
Constant -2.96 0.83 -3.59 .00 -4.60 -1.33 
n = 169 2R  = .22 (Adjusted 2R  = .20)  Root MSE = 1.93 
F(4,164) = 11.43, p = .00 
 
Ramsey RESET test using powers of the fitted values of Bulimia 
HO: model has no omitted variables 
F(3,161) = .55 
Prob > F .65 
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Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Bulimia 
χ² (1) = 70.31 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable bulimia and 
factor variables 5-HTTLPR, negative life events, STAI-T and neuroticism (Table 9) was 
estimated by F-statistic to be statistically significant (p < .05) and described 22% of variance 
seen in dependent variable Bulimia. Only factor variable STAI-T and constant of model were 
shown to be statistically significant (p < .05). 
The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
10). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 10 
Corrected regression analysis using robust standard errors 
Bulimia Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 
 
0.09 0.02 3.73 .00 0.04 0.13 
5-HTTLPR (l/l vs s-
allele carriers) 
0.27 0.30 0.88 .38 -0.33 0.86 
Neuroticism 0.00 0.01 0.16 .87 -0.01 0.01 
Negative life events 0.04 0.07 0.49 .63 -0.11 0.19 
 
Constant -2.96 0.82 -3.63 .00 -4.58 -1.35 
n = 169 2R  = .22  Root MSE = 1.93 
F(4,164) = 8.58, p = .00 
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Table 11 
Regression analysis using least squares method 
Bulimia Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.08 0.02 5.29 .00 0.05 0.12 
COMT Val/Met as a 
dummy variable 
 
0.28 0.37 0.75 .45 -0.46 1.02 
COMT Met/Met as a 
dummy variable 
 
-0.28 0.45 -0.62 .54 -1.15 0.60 
Neuroticism 0.00 0.01 0.33 .74 -0.01 0.02 
Negative life events 0.05 0.06 0.79 .43 -0.08 0.18 
       
Constant -2.70 0.75 -3.59 .00 -4.18 -1.21 
n = 169 2R  = .23 (Adjusted 2R  = .20)  Root MSE = 1.93 
F(5,163) = 9.47, p = .00 
 
Ramsey RESET test using powers of the fitted values of Bulimia 
HO: model has no omitted variables 
F(3,160) = .78 
Prob > F .51 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Bulimia 
χ² (1) = 65.21 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable bulimia and 
factor variables COMT gene Val158Met polymorphism dummy variables, negative life 
events, STAI-T and neuroticism (Table 11) was estimated by F-statistic to be statistically 
significant (p < .05) and described 23% of variance seen in dependent variable Bulimia. Only 
factor variable STAI-T and constant of model were shown to be statistically significant (p < 
.05). 
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The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
12). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 12 
Corrected regression analysis using robust standard errors 
Bulimia Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 
 
0.08 0.02 3.67 .00 0.04 0.13 
COMT Val/Met as a 
dummy variable 
 
0.28 0.47 0.61 .55 -0.64 1.20 
COMT Met/Met as a 
dummy variable 
 
-0.28 0.45 -0.61 .54 -1.17 0.62 
Neuroticism 0.00 0.01 0.36 .72 -0.01 0.02 
Negative life events 0.05 0.08 0.62 .53 -0.11 0.21 
       
Constant -2.70 0.61 -4.42 .00 -3.90 -1.49 
n = 169 2R  = .23  Root MSE = 1.93 
F(5,163) = 7.74, p = .00 
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Table 13 
Regression analysis using least squares method 
Drive for Thinness Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.17 0.03 5.07 .00 0.10 0.23 
5-HTTLPR (l/l vs s-
allele carriers) 
0.65 0.64 1.01 .31 -0.62 1.92 
Neuroticism -0.01 0.02 -0.89 .38 -0.04 0.02 
Negative life events -.01 0.13 1.38 .17 -0.08 0.44 
       
Constant -3.55 1.72 -2.07 .04 -6.94 -0.16 
n = 169 2R  = .18 (Adjusted 2R  = .16)  Root MSE = 4.02 
F(4,164) = 9.03, p = .00 
 
Ramsey RESET test using powers of the fitted values of Drive for Thinness 
HO: model has no omitted variables 
F(3,161) = .27 
Prob > F .84 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Drive for Thinness 
χ² (1) = 23.86 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable drive for 
thinness and factor variables 5-HTTLPR, negative life events, STAI-T and neuroticism 
(Table 13) was estimated by F-statistic to be statistically significant (p < .05) and described 
18% of variance seen in dependent variable drive for thinness. Only factor variable STAI-T 
and constant of model were shown to be statistically significant (p < .05). 
The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
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14). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 14 
Corrected regression analysis using robust standard errors 
Drive for Thinness Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.17 0.04 3.95 .00 0.08 0.25 
5-HTTLPR (l/l vs s-
allele carriers) 
0.65 0.65 1.00 .32 -0.64 1.94 
Neuroticism -0.01 0.02 -0.71 .48 -0.05 0.02 
Negative life events 0.18 0.15 1.22 .22 -0.11 0.47 
       
Constant -3.55 1.59 -2.23 .03 -6.69 -0.41 
n = 169 2R  = .18  Root MSE = 4.02 
F(4,164) = 7.22, p = .00 
 
 
Table 15 
Regression analysis using least squares method 
Drive for Thinness Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.16 0.03 4.95 .00 0.10 0.23 
COMT Val/Met as a 
dummy variable 
 
-0.34 0.78 -0.44 .66 -1.90 1.21 
COMT Met/Met as a 
dummy variable 
 
-0.64 0.93 -0.68 .50 -2.48 1.20 
Neuroticism -0.01 0.02 -0.84 .40 -0.04 0.02 
Negative life events 0.18 0.13 1.35 .18 -0.08 0.44 
       
Constant -2.09 1.57 -1.33 .19 -5.20 1.02 
n = 169 2R  = .18 (Adjusted 2R  = .15)  Root MSE = 4.04 
F(5,163) = 7.05, p = .00 
 
5-HTTLPR, COMT, adverse life events, anxiety, eating disorders 
 
56
 
Ramsey RESET test using powers of the fitted values of Drive for Thinness 
HO: model has no omitted variables 
F(3,160) = .39 
Prob > F .76 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Drive for Thinness 
χ² (1) = 26.07 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable drive for 
thinness and factor variables COMT gene Val158Met polymorphism dummy variables, 
negative life events, STAI-T and neuroticism (Table 15) was estimated by F-statistic to be 
statistically significant (p < .05) and described 18% of variance seen in dependent variable 
drive for thinness. Only factor variable STAI-T (p < .05) was shown to be statistically 
significant. 
The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
16). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
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Table 16 
Corrected regression analysis using robust standard errors 
Drive for Thinness Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.16 0.04 3.83 .00 0.08 0.25 
COMT Val/Met as a 
dummy variable 
 
-0.34 0.85 -0.40 .69 -2.02 1.33 
COMT Met/Met as a 
dummy variable 
 
-0.64 0.89 -0.72 .48 -2.39 1.12 
Neuroticism -0.01 0.02 -0.68 .50 -0.05 0.02 
Negative life events 0.18 0.16 1.15 .25 -0.13 0.49 
Constant -2.09 1.54 -1.36 .18 -5.13 0.95 
n = 169 2R  = .18 Root MSE = 4.04 
F(5,163) = 5.73, p = .00 
 
 
Table 17 
Regression analysis using least squares method 
Body Dissatisfaction Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.22 0.06 3.83 .00 0.11 0.34 
5-HTTLPR (l/l vs s-
allele carriers) 
-1.01 1.13 -0.90 .37 -3.24 1.22 
Neuroticism -0.01 0.03 -0.55 .58 -0.07 0.04 
Negative life events 0.44 0.23 1.90 .06 -0.02 0.89 
 
Constant 0.37 3.02 0.12 .90 -5.59 6.32 
n = 169 2R  = .14 (Adjusted 2R  = .12)  Root MSE = 7.06 
F(4,164) = 6.54, p = .00 
 
Ramsey RESET test using powers of the fitted values of Body Dissatisfaction 
HO: model has no omitted variables 
F(3,161) = 1.85 
Prob > F .14 
 
5-HTTLPR, COMT, adverse life events, anxiety, eating disorders 
 
58
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Body Dissatisfaction 
χ² (1) = 5.77 
Prob > χ² .02 
 
Regression model analyzing the relationship between dependent variable body 
dissatisfaction and factor variables 5-HTTLPR, negative life events, STAI-T and neuroticism 
(Table 17) was estimated by F-statistic to be statistically significant (p < .05) and described 
14% of variance seen in dependent variable body dissatisfaction. Only factor variable STAI-
T (p < .05) was shown to be statistically significant (p < .10). 
The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
18). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates.  
 
Table 18 
Corrected regression analysis using robust standard errors 
Body Dissatisfaction Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.22 0.06 3.74 .00 0.11 0.34 
5-HTTLPR (l/l vs s-
allele carriers) 
-1.01 1.19 -0.85 .40 -3.36 1.33 
Neuroticism -0.01 0.03 -0.49 .62 -0.07 0.04 
Negative life events 0.44 0.26 1.70 .09 -0.07 0.95 
       
Constant 0.37 2.92 0.13 .90 -5.40 6.13 
n = 169 2R  = .14  Root MSE = 7.06 
F(4,164) = 6.44, p = .00 
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Table 19 
Regression analysis using least squares method 
Body Dissatisfaction Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.23 0.06 3.92 .00 0.11 0.34 
COMT Val/Met as a 
dummy variable 
 
-2.35 1.37 -1.72 .09 -5.04 0.35 
COMT Met/Met as a 
dummy variable 
 
-1.38 1.62 -0.85 .40 -4.58 1.83 
Neuroticism -0.02 0.03 -0.82 .41 -0.07 0.03 
Negative life events 0.40 0.23 1.71 .09 -0.06 0.86 
       
Constant 0.89 2.74 0.33 .75 -4.52 6.30 
n = 169 2R  = .15 (Adjusted 2R  = .12)  Root MSE = 7.04 
F(5,163) = 5.70, p = .00 
 
Ramsey RESET test using powers of the fitted values of Body Dissatisfaction 
HO: model has no omitted variables 
F(3,160) = 2.24 
Prob > F .09 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Body Dissatisfaction 
χ² (1) = 7.91 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable body 
dissatisfaction and factor variables COMT gene Val158Met polymorphism dummy variables, 
negative life events, STAI-T and neuroticism (Table 19) was estimated by F-statistic to be 
statistically significant (p < .05) and described 15% of variance seen in dependent variable 
Body dissatisfaction. Only factor variable STAI-T (p < .05) was shown to be statistically 
significant (p < .10). 
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The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
20). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 20 
Corrected regression analysis using robust standard errors 
Body Dissatisfaction Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
STAI-T 0.23 0.06 3.85 .00 0.11 0.34 
COMT Val/Met as a 
dummy variable 
 
-2.35 1.61 -1.45 .15 -5.53 0.84 
COMT Met/Met as a 
dummy variable 
 
-1.38 1.78 -0.77 .44 -4.90 2.15 
Neuroticism -0.02 0.03 -0.75 .45 -0.08 0.04 
Negative life events 0.40 0.27 1.47 .14 -0.14 0.93 
Constant 0.89 2.88 0.31 .76 -4.79 6.57 
n = 169 2R  = .15 Root MSE = 7.04 
F(5,163) = 6.24, p = .00 
 
5-HTTLPR, COMT, adverse life events, anxiety, eating disorders 
 
61
Analysis regarding 5-HTTLPR / COMT Val158Met polymorphism, adverse life 
events, neuroticism, impulsivity and EDI-2 Bulimia results 
 
Table 21 
Pathway Analysis 
BIS-11 Coef. Std. Err. t P > | t | Beta 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
0.87 1.44 0.60 .55 .05 
Negative life events 
 
0.54 0.28 1.90 .06 .15 
Neuroticism 0.13 0.03 4.35 .00 .35 
Constant 
 
41.79 3.61 11.59 .00 . 
n = 140 2R  = .18 sqrt (1 - 2R ) = .91 
 
 
Bulimia Coef. Std. Err. t P > | t | Beta 
BIS-11 
 
0.04 0.02 1.93 .06 .17 
5-HTTLPR (l/l vs s-allele 
carriers) 
 
0.29 0.33 0.89 .37 .07 
Negative life events 
 
0.13 0.06 0.46 .65 .04 
Neuroticism 0.01 0.01 1.79 .08 .16 
Constant 
 
-2.80 1.16 -2.42 .02 . 
n = 140 2R  = .09 sqrt (1 - 2R ) = .95 
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Table 22 
Pathway Analysis 
BIS-11 Coef. Std. Err. t P > | t | Beta 
COMT Val/Met as dummy 
variable 
 
0.11 1.75 0.07 .95 .01 
COMT Met/Met as dummy 
variable 
 
1.15 2.06 0.56 .58 .05 
Neuroticism 0.13 0.03 4.33 .00 .35 
Negative life events 
 
0.51 0.29 1.76 .08 .14 
Constant 
 
42.88 3.28 13.09 .00 . 
n = 140 2R  = .18 sqrt (1 - 2R ) = .91 
 
 
Bulimia Coef. Std. Err. t P > | t | Beta 
BIS-11 
 
0.04 0.02 2.11 .04 .19 
COMT Val/Met as a 
dummy variable 
 
-0.35 0.39 -0.89 .38 -.09 
COMT Met/Met as a 
dummy variable 
 
-0.98 0.46 -2.12 .04 -.21 
Neuroticism 0.01 0.01 1.63 .11 .15 
Negative life events 0.04 0.07 0.57 .57 .05 
Constant 
 
-2.02 1.11 -1.82 .07 . 
n = 140 2R  = .12 sqrt (1 - 2R ) = .94 
 
5-HTTLPR, COMT, adverse life events, anxiety, eating disorders 
 
63
Diagnostics 
 
Table 23 
Regression analysis using least squares method 
BIS-11 Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
5-HTTLPR (l/l vs s-
allele carriers) 
 
0.87 1.44 0.60 .55 -1.97 3.70 
Negative life events 0.54 0.28 1.90 .06 -0.02 1.10 
Neuroticism 
 
0.13 0.03 4.35 .00 0.07 0.19 
Constant 
 
41.79 3.61 11.59 .00 34.66 48.92 
n = 140 2R  = .18 (Adjusted 2R  = .16)  Root MSE = 8.16 
F(3,136) = 9.68, p = .00 
 
Ramsey RESET test using powers of the fitted values of BIS-11 
HO: model has no omitted variables 
F(3,133) = .16 
Prob > F .92 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of BIS-11 
χ² (1) = .21 
Prob > χ² .65 
 
Regression model analyzing the relationship between dependent variable BIS-11 and 
factor variables 5-HTTLPR, negative life events and neuroticism (Table 23) was estimated by 
F-statistic to be statistically significant (p < .05) and described 16% of variance seen in 
dependent variable BIS-11. Only the factor variable neuroticism and constant of model were 
shown to be statistically significant (p < .05). The effect of negative life events was near 
significant (p = .06). 
The diagnostic tests show that no specification errors in terms of omitted variables 
and heteroskedasticity in significance levels p < .05 can be shown. 
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Table 24 
Regression analysis using least squares method 
Bulimia Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
BIS-11 0.04 0.02 1.93 .06 0.00 0.08 
5-HTTLPR (l/l vs s-
allele carriers) 
0.29 0.03 0.89 .37 -0.35 0.94 
Negative life events 0.03 0.06 0.46 .65 -0.10 0.16 
Neuroticism 0.01 0.01 1.76 .08 0.00 0.03 
 
Constant -2.80 1.16 -2.42 .02 -5.08 -0.51 
n = 140 2R  = .09 (Adjusted 2R  = .07)  Root MSE = 1.86 
F(4,135) = 3.44, p = .01 
 
Ramsey RESET test using powers of the fitted values of Bulimia 
HO: model has no omitted variables 
F(3,132) = .92 
Prob > F .43 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Bulimia 
χ² (1) = 21.52 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable bulimia and 
factor variables 5-HTTLPR, negative life events, BIS-11 and neuroticism (Table 24) was 
estimated by F-statistic to be statistically significant (p < .05) and described 9% of variance 
seen in dependent variable Bulimia. Constant of the model was shown to be statistically 
significant (p < .05). Factor variable BIS-11 (p = .06) and neuroticism (p = .08) was shown to 
be near significant. 
The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
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25). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 25 
Corrected regression analysis using robust standard errors 
Bulimia Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
BIS-11 
 
0.04 0.02 2.06 .04 0.00 0.07 
5-HTTLPR (l/l vs s-
allele carriers) 
0.29 0.28 1.04 .30 -0.26 0.85 
Negative life events 0.03 0.07 0.42 .68 -0.11 0.17 
Neuroticism 0.01 0.01 1.98 .05 0.00 0.03 
 
Constant -2.80 1.06 -2.64 .01 -4.89 -0.70 
n = 140 2R  = .09  Root MSE = 1.86 
F(4,135) = 4.67, p = .00 
 
 
Table 26 
Regression analysis using least squares method 
BIS-11 Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
COMT Val/Met as a 
dummy variable 
 
0.11 1.75 0.07 .95 -3.34 3.57 
COMT Met/Met as a 
dummy variable 
 
1.15 2.06 0.56 .58 -2.92 5.21 
Neuroticism 
 
0.13 0.03 4.33 .00 0.07 0.20 
Negative life events 
 
0.51 0.29 1.76 .08 -0.06 1.08 
Constant 
 
42.88 3.28 13.09 .00 36.40 49.36 
n = 140 2R  = .18 (Adjusted 2R  = .15)  Root MSE = 8.19 
F(4,135) = 7.22, p = .00 
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Ramsey RESET test using powers of the fitted values of BIS-11 
HO: model has no omitted variables 
F(3,132) = .11 
Prob > F .96 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of BIS-11 
χ² (1) = .19 
Prob > χ² .66 
 
Regression model analyzing the relationship between dependent variable impulsivity 
(BIS-11) and factor variables COMT gene Val158Met polymorphism as dummy variable, 
negative life events, BIS-11 and neuroticism (Table 26) was estimated by F-statistic to be 
statistically significant (p < .05) and described 18% of variance seen in dependent variable 
BIS-11. Constant of the model was shown to be statistically significant (p < .05). Factor 
variable neuroticism (p < .05) was shown to be significant. ). Negative life events (p = .08) 
was shown to be near significant. 
The diagnostic tests show that no specification errors in terms of omitted variables 
and heteroskedasticity were confirmed. 
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Table 27 
Regression analysis using least squares method 
Bulimia Coef. Std. 
Err. 
t P > | t | 95% Conf. Interval 
BIS-11 0.04 0.02 2.11 .04 0.00 0.08 
COMT Val/Met as a 
dummy variable 
 
-0.35 0.39 -0.89 .38 -1.12 0.43 
COMT Met/Met as a 
dummy variable 
 
-0.98 0.46 -2.12 .04 -1.89 -0.06 
Neuroticism 0.01 0.01 1.63 .11 0.00 0.03 
Negative life events 0.04 0.07 0.57 .57 -0.09 0.17 
       
Constant -2.02 1.11 -1.82 .07 -4.20 0.17 
n = 140 2R  = .12 (Adjusted 2R  = .08)  Root MSE = 1.84 
F(5,134) = 3.57, p = .00 
 
Ramsey RESET test using powers of the fitted values of Bulimia 
HO: model has no omitted variables 
F(3,131) = 1.48 
Prob > F .22 
 
Breusch-Pagan / Cook-Weisberg test for heteroskedasticity 
HO: Constant variance 
Variables: fitted values of Bulimia 
χ² (1) = 31.47 
Prob > χ² .00 
 
Regression model analyzing the relationship between dependent variable bulimia and 
factor variables COMT gene Val158Met polymorphism as dummy variable, negative life 
events, BIS-11 and neuroticism (Table 27) was estimated by F-statistic to be statistically 
significant (p < .05) and described 12% of variance seen in dependent variable Bulimia. Only 
factor variable BIS-11 and dummy variable COMT Val158Met Met/Met allele (p < .05). 
Constant of model was not statistically significant. 
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The diagnostic tests show that no specification errors in terms of omitted variables but 
heteroskedasticity was confirmed by Breusch-Pagan test (p < .05). New regression model 
with heteroskedasticity adjusted parameter’s standard error parameters was calculated (Table 
12). No change in terms statistically significant factors was seen after calculating a model 
with robust standard error estimates. 
 
Table 28 
Corrected regression analysis using robust standard errors 
Bulimia Coef. Robust 
Std. Err. 
t P > | t | 95% Conf. Interval 
BIS-11 
 
0.04 0.02 2.14 .04 0.00 0.08 
COMT Val/Met as a 
dummy variable 
 
-0.35 0.54 -0.64 .52 -1.41 0.72 
COMT Met/Met as a 
dummy variable 
 
-0.98 0.52 -1.87 .06 -2.01 0.06 
Neuroticism 0.01 0.01 1.84 .07 0.00 0.02 
Negative life events 0.04 0.08 0.48 .63 -0.12 0.19 
       
Constant -2.02 0.91 -2.23 .03 -3.81 -0.22 
n = 140 2R  = .12  Root MSE = 1.84 
F(5,134) = 4.16, p = .00 
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